Charles Rudin's guest appearances

Charles Rudin

GRACEcast Lung Cancer Video

GRACEcast Lung Cancer Audio

2016 ASCO Annual Meeting

Lung Cancer Considered

Nasser Hanna

Ben Solomon

Greg Riely

Lecia Sequist

Anne Tsao

David Spigel

Suresh Ramalingam

Nathan Pennell

Heather Wakelee

Robert Pirker

Alice Shaw

Rogerio Lilenbaum

Martin Reck

William Travis

Anthony Kim

OwlTail

Tripnara Sen

This episode of Lung Cancer Considered looks ahead to the IASLC 2021 Hot Topic Meeting on Small Cell Lung Cancer, scheduled for Oct 29th and 30th 2021. Host Dr. Stephen Liu discusses the state of the SCLC research with Dr. Tripnara Sen, an Assistant Attending Biologist in the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center and Dr. Charles Rudin, the co-director of the Druckenmiller Center for Lung Cancer Research and the Sylvia Hassenfeld Chair in Lung Cancer Research, also from Memorial Sloan Kettering.

SCLC Research - Charles Rudin and Tripnara Sen

Dr Rudin presents at ASCO 2016, early findings from a first-in-human clinical trial which showed that antibody drug conjugate (ADC) rovalpituzumab tesirine (Rova-T) demonstrated promising efficacy against recurrent small cell lung cancer (SCLC).

Antibody drug conjugate shows early promise in small cell lung cancer - Dr Charles Rudin

Dr. Charles Rudin from Johns Hopkins covers the work from the Lung Cancer Mutation Consortium that identified a wide range of molecular markers in patients with lung adenocarcinoma.

<p>Dr. Charles Rudin from Johns Hopkins covers the work from the Lung Cancer Mutation Consortium that identified a wide range of molecular markers in patients with lung adenocarcinoma.</p>

Molecular Markers in Lung Cancer Pt 1: Dr. Charles Rudin on The Lung Cancer Mutation Consortium (audio)